You are here

Fresh off one deal, Allergan CEO Saunders sets his sights on more

New York

ALLERGAN plc CEO Brent Saunders is ready to put the US$36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger.

The readiness for a new transaction just

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom